Drug intelligence / Profile preview

PEG-b-P[Asp(DET)]

Development stage
Preclinical
Modality
Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
Administration
Intravenous
01

Overview

PEG-b-P[Asp(DET)] is a **polymer-drug conjugate** consisting of **poly(ethylene glycol) (PEG)** covalently linked in a block copolymer structure to **poly(aspartamide) (PAsp) chains functionalized with diethylenetriamine (DET) groups**. This copolymer is engineered to form micelles for drug delivery, especially nucleic acids like siRNA or plasmid DNA[3]. The PEG segment provides steric stabilization, biocompatibility, and extends circulation time in vivo, while the P[Asp(DET)] segment offers cationic charge for complexation with negatively charged nucleic acids. In acidic environments (e.g., tumor tissue or endosomes), the DET groups are protonated, which triggers membrane destabilization, improved endosomal escape, and efficient intracellular delivery. This pH-sensitive feature enhances the release profiles and gene silencing activity of loaded nucleic acids[3]. PEG-b-P[Asp(DET)] does not act directly on molecular targets but functions as a **non-viral gene delivery carrier**. It has been developed primarily in academic settings for nanomedicine research and preclinical studies.

Other names
poly(ethylene glycol)-block-poly(aspartamide) with diethylenetriamine functionalizationPEG-b-poly(aspartamide)[diethylenetriamine]PEG-b-PAsp(DET)

Beyond the preview

Go deeper on PEG-b-P[Asp(DET)].

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on PEG-b-P[Asp(DET)].

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call